After the pharmaceutical Company GlaxoSmithKline PLC needed to reassess one of their manufacturing plants in Puerto Rico, they sent one of the Company’s quality assurance managers Cheryl Eckard. The former employee of the Company exposed severe abuses such as the production of a skin product for children that was poisonous.
Furthermore, Ms. Eckard observed that drugs often were mixed up in the same bottles in Puerto Rico, a dangerous mistake that has not been corrected.
Now, she gets awarded with $96 million for detecting the Company’s violations. The Puerto Rico plant was shut down after the incidents and GlaxoSmithKline PLC will be sued by the government for distributing harmful medication to its clients.
After Ms. Eckard’s investigations, she recommended to her Company to impose a shipping ban on all products from the plant, to stop the manufacture for at least 14 days in order to correct the mistakes and to inform the U. S. Food and Drug Administration about the conditions in Puerto Rico. Nevertheless, her requests were ignored by the Company.
As Eckard was not willing to cover up the violations in the Puerto Rico plant after 10 months of repeatedly trying to make her superiors act on it, she got fired by the firm. After she was made unemployed, she reported the documented violations to the FDA.